Efficacy of Temocillin compared to standard of care in the Treatment of Neisseria gonorrhoeae Infections: A Multicenter Randomized Controlled Non-Inferiority Trial (TEMtoGo).
This research study is looking at a new antibiotic, Temocillin, as a possible treatment for gonorrhoea, a common sexually transmitted infection. It's being compared to the current standard treatment to see if it works just as well. The main goal is to find out what percentage of people are completely free of the infection after treatment, checked about three weeks later at all infected areas like the genitals, throat, and anus. The study will also carefully watch for any side effects and how satisfied patients are with the treatment. This is a "Phase 3" study, meaning it's a key step in checking if a new treatment is safe and effective before it can be widely used.
At a glance
What is this study about?
This study is about finding new and effective ways to treat gonorrhoea, a common sexually transmitted infection. Doctors are testing a new antibiotic called Temocillin. They want to see if it works as well as the treatment currently used by doctors for gonorrhoea. This is really important because sometimes bacteria can become resistant to existing medicines, meaning the medicines stop working as well. Finding new treatments helps make sure we can continue to treat infections successfully.
The main thing the researchers want to figure out is if Temocillin can completely get rid of the gonorrhoea infection. They will check this by taking samples from different parts of the body that might be infected (like the genitals, throat, or anus) about three weeks after treatment begins. If the tests show no signs of gonorrhoea in all those areas, then the treatment is considered successful. They'll also be looking closely at any side effects people might have and asking patients about their experience with the treatment.
This type of study, called a "Phase 3" trial, is a big step in bringing new medicines to people. It helps confirm if a new treatment is safe and effective in a larger group of people before it can become a standard option. By comparing Temocillin to the usual treatment, researchers can decide if it's a good alternative that works just as well or even better, with acceptable side effects.
Key takeaways
- This study is testing a new antibiotic, Temocillin, for gonorrhoea.
- It aims to see if Temocillin is as good as the current usual treatment.
- Researchers will check if the infection completely clears up after treatment.
- They will also carefully look for any side effects.
- Participation involves several visits and samples over about three months.
Who may be eligible?
To join this study, you need to be an adult, 18 years old or older. The study is open to both men and women.
Because this study is about treating gonorrhoea, you would need to have been diagnosed with this infection to be considered for participation.
The research team will review your medical information to make sure participating is safe for you and that the study results will be clear and helpful. This includes checking for other health conditions or medications you might be taking.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Have you been diagnosed with gonorrhoea?
- Are you a man or a woman?
- Are you able to attend study appointments as required?
What does participation involve?
If you decide to take part in this study, you might receive either the new antibiotic, Temocillin, or the standard treatment currently used for gonorrhoea. You won't get to choose which one you receive – it's decided randomly, like flipping a coin. You'll need to attend several appointments, including at the start of the study, three weeks later (Day 21), and then another check-up around three months later.
During these visits, healthcare professionals will take samples, such as urine, swabs from your throat and anus, to check for the gonorrhoea infection. They'll also monitor you for any side effects and ask you questions about how you're feeling and your satisfaction with the treatment. The total time you'd be involved with the study would be about three months.
Potential risks and benefits
Locations (1)
- —UnverifiedFrance
Common questions
What is gonorrhoea?
Gonorrhoea is a common sexually transmitted infection (STI) caused by bacteria. It can infect the genitals, rectum, and throat.
What is a 'standard of care' treatment?
The 'standard of care' is the best available treatment that doctors currently use and is widely accepted for a particular condition.
Why is it important to find new treatments for gonorrhoea?
Bacteria, including those that cause gonorrhoea, can sometimes become resistant to antibiotics, meaning the medicines stop working. New treatments are needed to ensure we can keep treating the infection effectively.
Will I know if I'm getting the new drug or the standard one?
No, this is usually a 'blinded' study where neither you nor your doctor will know which treatment you are receiving until after the study is over. This helps ensure the results are fair and unbiased.
What does 'non-inferiority' mean in a study?
Non-inferiority means the study aims to show that the new treatment is at least as good as (not worse than) the standard treatment, rather than trying to prove it's better.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.